Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab

NCT01436617 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT01436617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01436617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab
Lead sponsor
Centre Francois Baclesse
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
March 31, 2013
Enrollment
303 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

allergic reaction, colon cancer, head and neck cancer